Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C

Gut

Volumn 51, Issue 2, 2002, Pages 248-252

  Wali, M ^a,b   Harrison, R F ^b   Gow, P J ^a   Mutimer, David ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; GRAFT REJECTION; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORGAN DONOR; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGED; AGING; DISEASE PROGRESSION; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036073498     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.2.248     Document Type: Article

References (27)

1. Long-term outcome of hepatitis C infection after liver transplantation
2. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C
3. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation
4. Cholestatic hepatitis C in liver allografts
5. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury
6. The outcome of hepatitis C virus infection after liver transplantation - Is it influenced by the type of immunosuppression?
7. HCV-related fibrosis progression following liver transplantation: Increase in recent years
8. Long-term outcome of hepatitis C virus infection after liver transplantation
9. Natural history of liver fibrosis progression in patients with chronic hepatitis C
10. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes
11. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation
12. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: Association with treatment of rejection
13. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients
14. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation
15. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation
16. Histological and clinical outcome after liver transplantation for hepatitis C
17. Histological grading and staging of chronic hepatitis
18. Risk factors for recurrence of hepatitis C after liver transplantation
19. Predictors of patient and graft survival following liver transplantation for hepatitis C
20. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate
21. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
22. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years
23. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
24. Outcome of de nova hepatitis C virus infection in heart transplant recipients
25. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection
26. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation
27. Liver transplantation in the United States from 1987-1998: Updated results from the Pitt-UNOS Liver Transplant Registry